Blog - Page 967 of 5701 - QualityStocks

TuesdayMay 31, 2022 1:24 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Exceptional Test Performance of Solid-State Polymer Battery

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced results of its solid-state polymer battery testing with the Battery Innovation Center (“BIC”) in Indiana. According to the update, BIC’s testing results show the solid-state polymer cell, rated at 300 Ah and 3.7 volts, tested in at 343.28 Ah at 4.2 volts, exceeding expectation and in line with test tolerance from previous EV Grid test results. Test data collected from both BIC and EV Grid demonstrate an impressive outcome and future for solid-state batteries. It is expected that with this technology, when scaled to the vehicle pack level,…

TuesdayMay 31, 2022 12:38 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Launch of JustCBD Products on Amazon.co.uk

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its wholly-owned subsidiary JustCBD will be launching its line of Novel Foods-registered CBD products on Amazon.co.uk. Since its entry into the now £700 million CBD market in October 2021, Amazon U.K. has expanded the initial pilot-only program to include vendors who have demonstrated compliance with U.K. CBD Novel Food regulations. Producers awarded U.K. Novel Food authorization must prove the product is safe for consumption and labeled correctly. “With health and wellness playing an increasingly important role in customers’ lives, we are…

TuesdayMay 31, 2022 12:00 pm

CWCBExpo, the Premier B2B Cannabis, and Hemp Expo and Conference to Foster Lively Discussion on Industry Opportunities and Challenges Among Seasoned Professionals and Newcomers Alike

The Cannabis World Congress & Business Exposition (CWCBExpo) will be held between June 2-4, 2022, at the Javits Convention Center, Hall 3A, in New York City. Industry heavyweights, the foremost innovators, and pioneering thought leaders will take the stage to discuss emerging trends in cannabis, hemp, and allied sectors. The expo will provide a high-quality business-focused attendee base located in the premier East Coast US cannabis and hemp market. The three-day event will feature an Inside the Industry: Thought Leadership Series in an interactive “Talk Show” format. Co-hosts will include Carl Cameron, veteran journalist and former FOX News reporter; Faye…

TuesdayMay 31, 2022 11:15 am

Silo Pharma Inc. (SILO) Focuses on Psilocybin’s Anti-Inflammatory Properties

On May 19, 2022, Silo Pharma (OTCQB: SILO) announced that The Translational Psychedelic Research (“TrPR”) Program at UCSF (University of California San Francisco) had “successfully dosed [with psilocybin] patients suffering from Parkinson’s disease.” TrPR connects researchers and medical professionals studying how psychedelics, including psilocybin, ketamine, etc., affect brain functions and other organ systems. Silo Pharma focuses on palliative uses of psychedelics for “PTSD, Parkinson’s, and other rare neurological disorders.” In teaming up with TrPR. Silo is exploring psilocybin’s anti-inflammatory possibilities in patients exhibiting signs of Parkinson’s Disease. Psilocybin’s journey from magic mushrooms to potential life savers has been a long,…

TuesdayMay 31, 2022 11:14 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Completes Major Step in Advancement of CYB003 for the Treatment of Major Depressive Disorder

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced the submission of an Investigational New Drug (“IND”) application to the U.S. Food and Drug Administration (“FDA”). According to the update, the IND is for Cybin’s phase 1/2a first-in-human clinical trial evaluating CYB003, a proprietary deuterated psilocybin analog, for the treatment of major depressive disorder (“MDD”). “Following the successful completion of our IND-enabling work just last month, we are very excited to have reached this major milestone toward advancing CYB003 into clinical development so quickly. Based on preclinical studies, our proprietary psilocybin analog…

TuesdayMay 31, 2022 11:05 am

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR) Releases Q1 2022 Financial Report

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR), a propriety SaaS technology company delivering mobile-first live-dealer technology to online gaming operators globally, is reporting its first quarter 2022 financial numbers; the report is for the quarter ended March 31, 2022. Highlights of the report include company revenues of $140,877, which came from Playgon’s Live Dealer platform. The company noted that it saw increased player betting throughout the quarter, a strong indicator for future revenue growth. In addition, Playgon observed an increase in player win percentage resulting in reduced house margins. The company also reported loss for the quarter of $3,899,555,…

TuesdayMay 31, 2022 10:48 am

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Shares Update on Filing of Audit, 2021 Financials

Eat Well Group (CSE: EWG) (OTC: EWGFF), a publicly traded investment company, has released an update regarding the anticipated timelines for the filing of its audited annual financial statements for the year ended Nov. 30, 2021, as well as other required documents, including the related management’s discussion and analysis and certificates of its CEO and CFO. The announcement noted that additional delays have taken place, although the company and its auditors continue to work diligently to file the required documents as soon as possible. According to the most recent estimates, the company plans on filing the information by June 10,…

TuesdayMay 31, 2022 10:30 am

Mullen Automotive Inc. (NASDAQ: MULN) Working to Alleviate Consumer Anxiety by Offering EVs with 600-Plus Mile Range

J.D. Power survey reports range was factor most cited in deciding what EV to buy Mullen is making significant strides toward producing vehicles that feature some of the longest ranges available in the EV space Recognizing the critical role of battery and range in the success of an EV, Mullen is exploring other advanced battery technologies One of the challenges preventing enthusiastic acceptance of electric vehicles is range anxiety, fear that an electric car will run out of battery or fuel before the driver can reach their destination or a charging station. The concern is valid — a January 2022…

TuesdayMay 31, 2022 9:45 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) and Kernel Report Result of Study Measuring Ketamine’s Effects on the Brain

Study shows that COVID-19 pandemic has affected mental health of 59% of U.S. population, intensifying already-serious issue CYBN-sponsored feasibility study indicates ketamine-induced changes in brain’s functional connectivity persisted for several days after receiving the substance Kernel Flow pivotal in developing most accurate, effective treatment regimens for patients The challenges associated with mental-health issues are rising, following the global pandemic. Already a serious problem before COVID-19, mental health has become even more pressing now, with many companies committed to offering relief to the nearly 1 billion people worldwide who deal with mental-health issues. Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical…

Site Search

Company Search